- Economic Impact
- Nano Network
Associate Professor, Reed College
Microtechnology-Based Energy and Chemical Systems
Jay Mellies received a Bachelor of Science in Biochemistry from the University of California at Davis. After three years at the biotech company Microgenics, Corp., dedicated to developing human medical diagnostic tools, he entered graduate study, receiving a Ph.D. in Microbiology, also from UC Davis, in 1994. Dr. Mellies was an Alexander von Humboldt fellow at the Max Planck Institute for Infectious Biology in Tübingen, Germany, for three years, then took a second post-doctoral position at the University of Maryland School of Medicine at Baltimore, in the Center for Vaccine Development, from 1997-1999. In the fall of 1999, he joined the Reed College Biology Department, where he is currently an Associate Professor. He has maintained a decade of research funding from the National Institutes of Health for investigating the molecular pathogenesis of enteropathogenic Escherichia coli and the related bacterium of serotype O157:H7 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659682), which is a serious threat to public health in the US and other developed countries. He also obtained funding from the Defense Advanced Projects Agency (DARPA) to develop the Caenorhabditis elegans small animal infection model for studying pathogenic E. coli bacteria (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346621), and has published articles in several national and international journals.